Anne Layne-Farrar

She advises clients on competition, intellectual property, regulation, and policy issues across a broad range of industries and has worked with some of the largest information technology, communications, and pharmaceutical companies in the world. Dr. Layne-Farrar has advised clients in a variety of jurisdictions, including the US, Europe, and Asia (South Korea and China).

Dr. Layne-Farrar’s expert work for industry leading clients has included analyzing reasonable licensing, including RAND and FRAND; calculating damages; assessing economic incentives and firm behavior within standard setting organizations; reviewing the competitive implications of licensing pharmaceuticals; defining markets; and determining costs and benefits for legislative proposals covering healthcare, credit and debit cards, labor unions, television ratings, software security, and e-commerce.

Dr. Layne-Farrar has given oral and written expert testimony in a variety of US courts and has provided other submissions, including ones before the US Supreme Court and before regulatory bodies including the US Federal Trade Commission, the US Department of Justice, the US Senate, the European Commission, and MOFCOM.

Additionally, she has presented at academic and industry conferences around the world and is widely published. She coauthored a book on law and economics, has published articles in magazines including Antitrust, Global Competition Review, and Regulation and in academic journals, including Antitrust Law Journal, International Journal of Industrial Organization, and Journal of Competition Law and Economics.